Combat muscle loss with this 7-move routine.

GLP-1 receptor agonists, the class of drugs that includes semaglutide and similar medications now widely prescribed for ...

The GLP-1 wave has triggered a broader biopharma M&A cycle, and these five biotech companies represent compelling acquisition ...

What will the future world of GLP-1 drugs look like? From Eli Lilly's Foundayo to triple-strength Wegovy, discover the ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

GLP-1RAs reduced CRC risk by 35.7% compared to aspirin, with greater reductions in high-risk patients and younger individuals. GLP-1RAs showed a favorable safety profile, with lower rates of ...

Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...

Please provide your email address to receive an email when new articles are posted on . A narrative review found that GLP-1 receptor agonists may significantly lower risks for ocular hypertension and ...

There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...